Cadence Bank Na Abb Vie Inc. Transaction History

Cadence Bank Na

$16.1 Million
Q3 2022

A detailed history of Cadence Bank Na transactions in Abb Vie Inc. stock. As of the latest transaction made, Cadence Bank Na holds 3,029 shares of ABBV stock, worth $506,600. This represents 2.52% of its overall portfolio holdings.

Number of Shares

3,029

Previous 16,101 81.19%

Holding current value

$506,600

Previous $2.47 Million 83.54%

% of portfolio

2.52%

Previous 0.8%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $1.75 Million - $2.01 Million	-13,072 Reduced 81.19%	3,029 $406,000
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $47,203 - $60,011	343 Added 2.18%	16,101 $2.47 Million
Q1 2022 Apr 18, 2022	BUY	$131.98 - $163.75 $61,634 - $76,471	467 Added 3.05%	15,758 $2.56 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $752 - $951	7 Added 0.05%	15,291 $2.07 Million
Q3 2021 Oct 22, 2021	SELL	$106.4 - $120.78 $12,023 - $13,648	-113 Reduced 0.73%	15,284 $1.65 Million

Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $50,185 - $55,909	-477 Reduced 3.0%	15,397 $1.74 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $123,578 - $136,044	1,208 Added 8.24%	15,874 $1.72 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $54,411 - $73,460	676 Added 4.83%	14,666 $1.57 Million
Q3 2020 Oct 23, 2020	SELL	$85.91 - $100.83 $8,075 - $9,478	-94 Reduced 0.67%	13,990 $1.23 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $98,169 - $131,364	1,338 Added 10.5%	14,084 $1.38 Million
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $59,791 - $90,651	-927 Reduced 6.78%	12,746 $972,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $9,665 - $12,093	134 Added 0.99%	13,673 $1.21 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $85,400 - $102,676	-1,356 Reduced 9.1%	13,539 $1.03 Million
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $98,681 - $126,137	1,502 Added 11.21%	14,895 $1.08 Million
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $107,841 - $126,924	-1,398 Reduced 9.45%	13,393 $1.08 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $39,547 - $48,773	-508 Reduced 3.32%	14,791 $1.36 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $56,902 - $63,257	-640 Reduced 4.02%	15,299 $1.45 Million
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $11,132 - $13,172	124 Added 0.78%	15,939 $1.48 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $71,767 - $96,103	-780 Reduced 4.7%	15,815 $1.5 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $26,509 - $29,070	-296 Reduced 1.75%	16,595 $1.61 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $1.18 Million - $1.51 Million	16,891	16,891 $1.5 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank Na with notifications on news.

Account